Bayforest Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
2,988
+928
+45% +$74.8K 0.23% 108
2026
Q1
$146K Sell
2,060
-625
-23% -$46.8K 0.16% 226
2025
Q4
$212K Sell
2,685
-1,107
-29% -$87.6K 0.16% 267
2025
Q3
$312K Sell
3,792
-7,671
-67% -$604K 0.15% 279
2025
Q2
$922K Buy
11,463
+9,772
+578% +$754K 0.4% 50
2025
Q1
$136K Buy
1,691
+1,119
+196% +$93.1K 0.06% 450
2024
Q4
$46.8K Buy
+572
New +$47.6K 0.06% 483

Other funds holding MET

Bayforest Capital's MET Position: Q2 2026 in Review

Bayforest Capital increased its MetLife (MET) stake by 45% in Q2 2026, buying an estimated $74.8K and bringing the position to 2,988 shares worth $253K. The position accounts for 0.23% of the portfolio, ranked #108.

Bayforest Capital first reported a position in MET in Q4 2024 and has held it in 7 quarters since. The position peaked at $922K in Q2 2025. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Bayforest Capital held 2,988 shares of MetLife worth $253K as of Q2 2026.
  • Bayforest Capital bought 928 MetLife shares in Q2 2026, an estimated $74.8K.
  • MetLife made up 0.23% of Bayforest Capital's portfolio in Q2 2026, its #108 holding.
  • Bayforest Capital first reported a position in MetLife in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's MetLife position peaked at $922K in Q2 2025.
  • 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.